Detalhe da pesquisa
1.
An Irf6-Esrp1/2 regulatory axis controls midface morphogenesis in vertebrates.
Development
; 147(24)2020 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-33234718
2.
Diagnostic accuracy of general dermatologists and supportive oncodermatologists for biopsied cutaneous immune-related adverse events.
Support Care Cancer
; 30(10): 7827-7831, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35804176
3.
The TFAP2A-IRF6-GRHL3 genetic pathway is conserved in neurulation.
Hum Mol Genet
; 28(10): 1726-1737, 2019 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30689861
4.
Rapid functional analysis of computationally complex rare human IRF6 gene variants using a novel zebrafish model.
PLoS Genet
; 13(9): e1007009, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28945736
5.
Sun exposure and protection practices in children after allogeneic hematopoietic stem cell transplantation: A Survey-Based Cross-Sectional Cohort Study.
Pediatr Dermatol
; 36(6): 882-886, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31410910
6.
Association between common medication triggers and severity of cutaneous immune-related adverse events.
J Am Acad Dermatol
; 86(5): 1137-1140, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33878407
7.
Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors.
J Am Acad Dermatol
; 86(4): 886-889, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33722547
8.
Synergistic roles of Wnt modulators R-spondin2 and R-spondin3 in craniofacial morphogenesis and dental development.
Sci Rep
; 11(1): 5871, 2021 03 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33712657
9.
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer.
JAMA Dermatol
; 157(5): 577-582, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33760001
10.
CRISPR Craft: DNA Editing the Reconstructive Ladder.
Plast Reconstr Surg
; 142(5): 1355-1364, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30511992
11.
Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer.
JAMA Dermatol
; 2021 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33851976